NIAGEN BIOSCIENCE, INC. Other Nonoperating Income (Expense)
NIAGEN BIOSCIENCE, INC. (NAGE) reported Other Nonoperating Income (Expense) of -$65.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2018-11-07
- NIAGEN BIOSCIENCE, INC. other nonoperating income (expense) for the quarter ending 2018-09-30 was $0.00.
- NIAGEN BIOSCIENCE, INC. other nonoperating income (expense) for the quarter ending 2018-06-30 was -$65.00K.
- NIAGEN BIOSCIENCE, INC. other nonoperating income (expense) for the quarter ending 2017-09-30 was $0.00.
- NIAGEN BIOSCIENCE, INC. other nonoperating income (expense) for the quarter ending 2017-07-01 was $0.00.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month |
|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$65.00K derived: sum of 2 quarters · filed 2018-11-07 | -$65.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$65.00K 10-Q · filed 2018-08-09 | -$65.00K 10-Q · filed 2018-08-09 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 |
| 2017-07-01 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |